Literature DB >> 19285048

Vascular endothelial growth factor-stimulated cerebral microvascular endothelial cells mediate the recruitment of neural stem cells to the neurovascular niche.

Nils O Schmidt1, Dennis Koeder2, Markus Messing2, Franz-Josef Mueller3, Karen S Aboody4, Seung U Kim5, Peter M Black6, Rona S Carroll6, Manfred Westphal2, Katrin Lamszus2.   

Abstract

Endogenous and transplanted neural stem cells (NSC) are highly migratory and display a unique tropism for areas of neuro-pathology. However, signals controlling NSC motility in health and disease are still ill-defined. NSC appear to be intimately associated with the cerebral vasculature and angiogenesis is a hallmark of many neurological disorders. This has led us to investigate the influence of quiescent and angiogenically active human endothelial cells on human NSC migration. In vivo we observed frequent perivascular accumulation of human NSC in the proximity of cerebral microvessels upon induction of angiogenesis by cerebral infusion of vascular endothelial growth factor (VEGF) into the murine brain. We analyzed the in vitro effects of conditioned media from human endothelial cells before and after angiogenic stimulation with VEGF on the migration of human NSC in vitro. Non-stimulated endothelial cells induced a moderate chemotactic migration that was significantly enhanced after angiogenic activation by VEGF. In order to identify cytokines that may function as stimulators of NSC chemotaxis, we screened endothelial cell-conditioned media for the expression of 120 different cytokines. We identified PDGF-BB, RANTES, I-TAC, NAP-2, GROalpha, Ang-2, and M-CSF as endothelial cell-released chemoattractants for human NSC in vitro. VEGF-stimulated cerebral microvascular endothelial cells secreted higher levels of Ang-2 and GROalpha, which in part were responsible for the enhanced chemoattraction of NSC. Our findings support the hypothesis that the angiogenically active microvasculature modulates the local guidance of NSC through endothelial cell-derived chemoattractants.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19285048     DOI: 10.1016/j.brainres.2009.02.065

Source DB:  PubMed          Journal:  Brain Res        ISSN: 0006-8993            Impact factor:   3.252


  38 in total

1.  Evolution of the VEGF-regulated vascular network from a neural guidance system.

Authors:  Sreenivasan Ponnambalam; Mario Alberghina
Journal:  Mol Neurobiol       Date:  2011-01-28       Impact factor: 5.590

Review 2.  Migration and fate of therapeutic stem cells in different brain disease models.

Authors:  B J Carney; K Shah
Journal:  Neuroscience       Date:  2011-09-14       Impact factor: 3.590

3.  Differentiation state determines neural effects on microvascular endothelial cells.

Authors:  Lara A Muffley; Shin-Chen Pan; Andria N Smith; Maricar Ga; Anne M Hocking; Nicole S Gibran
Journal:  Exp Cell Res       Date:  2012-06-07       Impact factor: 3.905

4.  Adult neurogenesis and neurodegenerative diseases: A systems biology perspective.

Authors:  Emrin Horgusluoglu; Kelly Nudelman; Kwangsik Nho; Andrew J Saykin
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2016-02-16       Impact factor: 3.568

Review 5.  Diverse roles of the vasculature within the neural stem cell niche.

Authors:  Joshua S Goldberg; Karen K Hirschi
Journal:  Regen Med       Date:  2009-11       Impact factor: 3.806

6.  A comparative study of neural and mesenchymal stem cell-based carriers for oncolytic adenovirus in a model of malignant glioma.

Authors:  Atique U Ahmed; Matthew A Tyler; Bart Thaci; Nikita G Alexiades; Yu Han; Ilya V Ulasov; Maciej S Lesniak
Journal:  Mol Pharm       Date:  2011-06-30       Impact factor: 4.939

Review 7.  Opportunities and challenges: stem cell-based therapy for the treatment of ischemic stroke.

Authors:  Yao-Hui Tang; Yuan-Yuan Ma; Zhi-Jun Zhang; Yong-Ting Wang; Guo-Yuan Yang
Journal:  CNS Neurosci Ther       Date:  2015-02-10       Impact factor: 5.243

8.  Neural stem cell therapy of foetal onset hydrocephalus using the HTx rat as experimental model.

Authors:  Roberto Henzi; Karin Vío; Clara Jara; Conrad E Johanson; James P McAllister; Esteban M Rodríguez; Montserrat Guerra
Journal:  Cell Tissue Res       Date:  2020-02-17       Impact factor: 5.249

9.  Pharmacological neuroprotection after perinatal hypoxic-ischemic brain injury.

Authors:  Xiyong Fan; Annemieke Kavelaars; Cobi J Heijnen; Floris Groenendaal; Frank van Bel
Journal:  Curr Neuropharmacol       Date:  2010-12       Impact factor: 7.363

Review 10.  Mesenchymal stem cells as a double-edged sword in suppression or progression of solid tumor cells.

Authors:  Fatemeh Norozi; Ahmad Ahmadzadeh; Saeid Shahrabi; Tina Vosoughi; Najmaldin Saki
Journal:  Tumour Biol       Date:  2016-07-20
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.